Form 4: IBM Vice Chairman Gary D. Cohn Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


IBM's Vice Chairman, Gary D. Cohn, reported the vesting of restricted stock units and the subsequent withholding of shares to cover taxes.

Summary

  • Gary D. Cohn, Vice Chairman of IBM, reported a transaction involving restricted stock units (RSUs) on January 4, 2025.
  • A total of 5,114 RSUs vested, which were converted into common stock.
  • Following the vesting, 2,197 shares were withheld to cover tax obligations at a price of $222.075 per share.
  • After these transactions, Mr. Cohn's direct holdings of IBM common stock decreased to 70,745.338 shares.

Sentiment

Score: 5

Explanation: The document is a routine disclosure of stock transactions, which is neither positive nor negative for the company's performance.

Industry Context

This is a routine disclosure of stock transactions by a company executive, which is common practice for publicly traded companies.

Comparison to Industry Standards

  • Executive stock transactions are a standard part of compensation packages in publicly traded companies like IBM.
  • The vesting schedule and tax withholding practices are typical for RSU grants.
  • Other large technology companies such as Microsoft, Apple, and Google also regularly report similar transactions by their executives.

Stakeholder Impact

  • The transaction has a minor impact on the total number of outstanding shares of IBM.
  • The tax withholding benefits the government.

Key Dates

DateDescription
01/04/2021Date of original grant of 19,794 RSUs.
11/03/2021Date of Kyndryl Holdings, Inc. spin-off, which resulted in an adjustment to unvested IBM RSUs.
01/04/2022First vesting date of 4,948 RSUs.
01/04/2023Second vesting date of 4,949 RSUs.
01/04/2024Third vesting date of 4,948 RSUs.
01/04/2025Final vesting date of 4,949 RSUs and the date of the reported transaction.
01/06/2025Date the Form 4 was signed.

Keywords

IBM, insider trading, stock transaction, restricted stock units, RSU, Gary D. Cohn, Form 4, executive compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.